Profund Advisors LLC Arcutis Biotherapeutics, Inc. Transaction History
Profund Advisors LLC
- $2.59 Billion
- Q3 2024
A detailed history of Profund Advisors LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 54,582 shares of ARQT stock, worth $748,319. This represents 0.02% of its overall portfolio holdings.
Number of Shares
54,582
Previous 48,190
13.26%
Holding current value
$748,319
Previous $448,000
13.17%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding ARQT
# of Institutions
197Shares Held
129MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC11.7MShares$160 Million0.07% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$150 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$147 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$120 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$118 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $825M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...